The database
Compounds
150 compounds, grouped by what people use them for. Every page cites its sources.
- Weight loss35
- Muscle & strength18
- Injury & recovery12
- Skin & hair21
- Sleep & focus18
- Libido & hormones15
- Longevity16
- Immunity12
- Gut3
Weight loss 35
FDA Approved 8
- Weight loss · Weekly shotSemaglutideGLP-1The weekly shot the FDA approved as Ozempic and Wegovy. Weight loss in its main trial: 14.9%, on average.Approved drugFDA approvedChecked Oct 18
- Weight loss · Weekly shotTirzepatideGLP-1Zepbound: the weekly shot that beat semaglutide head-to-head. Main trial: 20.9% weight loss at 72 weeks.Approved drugFDA approvedChecked Oct 18
- Weight loss · Daily shotLiraglutideGLP-1The daily shot before Ozempic, approved for teenagers from 12. Its main trial: 8% weight loss at 56 weeks.Approved drugFDA approvedChecked Oct 18
- Weight loss · PillOrforglipronGLP-1Foundayo: a daily weight-loss pill with no fasting rules. Phase 3: 11.2% weight loss at 72 weeks.Approved drugFDA approvedChecked Oct 18
- Weight loss · Daily shotSetmelanotideMelanocortinFor rare genetic obesity, not everyday weight loss. Phase 3: 8 of 10 patients lost at least 10% in a year.Approved drugFDA approvedChecked Oct 13
- Weight loss · Weekly shotDulaglutideGLP-1Trulicity: a weekly diabetes shot, not a weight-loss drug. The AWARD trials: 2–5 kg lost.Controlled trialsFDA approvedfor another useChecked Oct 18
- Weight loss · Daily shotExenatideGLP-1Byetta, the diabetes shot copied from Gila monster venom. Obese, no diabetes: 3.3% of weight beyond placebo.Controlled trialsFDA approvedfor another useChecked Oct 17
- Weight loss · Daily shotPramlintideAmylinApproved in 2005 for diabetics on insulin: three shots a day, boxed warning. Not a weight-loss drug.Controlled trialsFDA approvedfor another useChecked Oct 18
Gray Market 27
- Weight loss · Weekly shotRetatrutideGLP-1Lilly's triple-hormone shot, unapproved; gray-market copies sell anyway. Phase 3: 25.0% loss at 80 weeks.Controlled trialsGray marketChecked Oct 12
- Weight loss · Weekly shotCagrilintideAmylinThe other half of Novo's CagriSema combo. Alone it's gray-market; paired, 20.4% weight loss at 68 weeks.Controlled trialsGray marketChecked Oct 18
- Weight loss · Daily shotAOD-9604GH fragmentSold as growth hormone's fat-burning fragment. Its biggest trial, 502 people over 24 weeks, missed its goal.Controlled trialsGray marketChecked Oct 18
- Weight loss · Weekly shotMazdutideGLP-1Prescribed in China since 2025; not approved in the US. Main trial: 12.6% weight loss at 32 weeks.Controlled trialsGray marketChecked Oct 12
- Weight loss · Weekly shotSurvodutideGLP-1Boehringer's two-in-one weight-loss shot, in Phase 3. Phase 2 beat placebo by up to 12 points of body weight.Controlled trialsGray marketChecked Oct 18
- Weight loss · Weekly shotPetrelintideAmylinPitched as the weight-loss shot you can stay on. Phase 2: up to 9.8% at 28 weeks against 1.7% on placebo.Controlled trialsGray marketChecked Oct 18
- Weight loss · Weekly shotEloralintideAmylinLilly's next weight-loss shot, in trials only. Phase 2: 20% weight loss at 48 weeks in 263 adults.Controlled trialsGray marketChecked Oct 13
- Weight loss · Weekly shotAmycretinAmylinNovo's next weight-loss shot and pill, trials only. Every published result: Novo-funded trials, 759 people.Controlled trialsGray marketChecked Oct 18
- Weight loss · IV dripBimagrumabMyostatin blockerAlso for Muscle & strengthPitched as fat loss that keeps muscle. Alone, it took off less weight than semaglutide in a 507-adult trial.Controlled trialsGray marketChecked Oct 5
- Weight loss · Weekly shotCagriSemaAmylinNovo's two-drug shot built to beat Zepbound. 20.4% weight loss in Phase 3; the FDA hasn't ruled yet.Controlled trialsGray marketChecked Oct 18
- Weight loss · Weekly shotEcnoglutideGLP-1China's weekly weight-loss shot, billed as beating semaglutide. The proof: a conference poster at week 20.Controlled trialsGray marketChecked Oct 18
- Weight loss · Monthly shotMariTideGLP-1Amgen's bid for a once-a-month obesity shot. In print so far: one efficacy trial, 592 people, Amgen-funded.Controlled trialsGray marketChecked Oct 18
- Weight loss · Weekly shotPemvidutideGLP-1Altimmune's two-in-one weight-loss shot, in trials only. Phase 2: 15.6% loss at 48 weeks in 391 adults.Controlled trialsGray marketChecked Oct 11
- Weight loss · PillTesofensineSmall moleculeBack on the gray market since the weight-loss-shot shortages. Phase 2: 9.2% loss in 24 weeks; no Phase 3.Controlled trialsGray marketChecked Oct 18
- Weight loss · Weekly shotVK2735GLP-1Viking's rival to Mounjaro, in trials only. Phase 2: 14.7% weight loss in 13 weeks at the top dose.Controlled trialsGray marketChecked Oct 18
- Weight loss · PillCardarineSmall moleculeTaken as an exercise pill for fat loss. Its maker quit after 2-year rodent tests found tumors at every dose.Human pilotsGray marketTumors in rats and mice at every doseChecked Oct 12
- Weight loss · Weekly shotCT-388GLP-1Roche's weekly weight-loss shot, still in trials. Phase 2 poster, top dose: 18.3% beyond placebo at 48 weeks.Human pilotsGray marketChecked Oct 5
- Weight loss · Weekly shotGlumitideGIPLilly's trial-only shot, built from one half of Zepbound. Data: two Phase 1 studies, four weeks of dosing.Human pilotsGray marketChecked Oct 18
- Weight loss · Pill5-Amino-1MQSmall moleculeSold as a fat-loss pill for a stubborn metabolism. Every fat-loss result so far: obese mice, from one lab.Animal onlyGray marketChecked Oct 11
- Weight loss · Daily shotAdipotideCell-killing peptidePitched as a way to starve fat cells of blood. Obese monkeys lost 11% of their fat; their kidneys objected.Animal onlyGray marketKidney injury in monkeysChecked Oct 18
- Weight lossAICARSmall moleculeSold as exercise in a pill. The 2008 mice ran 44% farther; no human trial has matched it.Animal onlyGray marketChecked Oct 18
- Weight lossBAM15MitochondrialA research chemical that makes mitochondria waste fuel. In mice it stopped fat gain; human trials: zero.Animal onlyGray marketChecked Oct 12
- Weight loss · PillGW-0742Small moleculeA PPAR-delta agonist pitched as exercise in a pill. The evidence: mouse muscle papers; human trials: zero.Animal onlyGray marketChecked Oct 18
- Weight loss · Daily shotHGH Fragment 176-191GH fragmentSold as 'HGH frag' for fat loss. Human trials of this exact fragment: zero; its cousin AOD-9604 failed.Animal onlyGray marketChecked Oct 18
- Weight lossNesfatin-1NeuropeptideStudied since 2006 as an appetite brake. It has never been given to a person in a trial.Animal onlyGray marketChecked Oct 18
- Weight loss · PillSLU-PP-332Small moleculeA pill pitched as a workout substitute. The evidence: one 2023 mouse paper where mice ran 70% farther.Animal onlyGray marketChecked Oct 18
- Weight loss · PillSR9009Small moleculeSold online as exercise in a pill. The fat loss came from mice injected for 30 days; no human trial.Animal onlyGray marketCase report: liver failure, transplantChecked Oct 12
Also here: Tirzepatide · Setmelanotide · Dulaglutide · Exenatide · Pramlintide · Retatrutide · Cagrilintide · AOD-9604 · Mazdutide · Survodutide · Petrelintide · Eloralintide · Amycretin · Bimagrumab · CagriSema · Ecnoglutide · MariTide · Pemvidutide · Tesofensine · VK2735 · Cardarine · CT-388 · Glumitide · 5-Amino-1MQ · Adipotide · AICAR · BAM15 · GW-0742 · HGH Fragment 176-191 · Nesfatin-1 · SLU-PP-332 · SR9009
All 35 in Weight loss →Muscle & strength 18
FDA Approved 3
- Muscle & strength · Daily shotTesamorelinGH secretagogueAlso for Weight lossApproved for HIV-related belly fat; clinics use it off-label. Its 412-patient trial cut belly fat 15–18%.Approved drugFDA approvedChecked Oct 18
- Muscle & strength · Daily shotHGHHormoneAlso for LongevityAnti-aging clinics sell it for body composition. That story began with 12 men in a 1990 study.Approved drugFDA approvedChecked Oct 5
- Muscle & strength · PillMacimorelinGH secretagogueMacrilen: a drink that tests adults for low growth hormone. It missed 19 of 74 the insulin test flagged.Human pilotsFDA approvedfor another useChecked Oct 5
Compounded Rx 1
Gray Market 14
- Muscle & strength · Daily shotGHRP-2GH secretagogueClinic users inject it 2–3 times a day. Its only approval: a one-shot growth-hormone test in Japan, 2004.Controlled trialsGray marketChecked Oct 18
- Muscle & strength · PillMK-677GH secretagogueAlso for Sleep & focusTaken nightly for growth hormone and sleep. A year-long trial: +1.1 kg lean mass, no strength gain.Controlled trialsGray marketTrial stopped early over heart failureChecked Oct 18
- Muscle & strength · ShotACE-031Myostatin blockerSold to lifters as a muscle-brake blocker. Top dose: lean mass +3.3% in women 45–75; a boys’ trial stopped.Controlled trialsGray marketTrial stopped over nosebleedsChecked Oct 5
- Muscle & strength · PillAnamorelinGH secretagogueJapan’s Adlumiz, a pill for cancer wasting. In 979 lung-cancer patients, lean mass rose; grip strength didn’t.Controlled trialsGray marketLife-threatening heart rhythms in case reportsChecked Oct 5
- Muscle & strength · Weekly shotCJC-1295GH secretagogueAnti-aging clinics pair it with ipamorelin for growth hormone. Human data: 78 people in three Phase 1 trials.Human pilotsGray marketChecked Oct 18
- Muscle & strength · Daily shotIpamorelinGH secretagogueAlso for Sleep & focusSold as the polite growth-hormone releaser that spares cortisol. That claim traces to a 1998 study in pigs.Human pilotsGray marketChecked Oct 18
- Muscle & strength · Daily shotGHRP-6GH secretagogueThe 1984 original, now taken mostly for its hunger kick. Its GH data in people: short tests, 1 record review.Human pilotsGray marketChecked Oct 13
- Muscle & strength · Daily shotHexarelinGH secretagogueKnown for the biggest growth-hormone pulse of its family. The catch: it fades within 2–4 weeks of daily use.Human pilotsGray marketChecked Oct 18
- Muscle & strengthFollistatin-344Myostatin blockerBodybuilders buy vials to lift the body's muscle brake. Controlled human trials of vial follistatin: zero.Animal onlyGray marketChecked Oct 18
- Muscle & strengthIGF-1 DESIGF-1 variantBodybuilders inject it into a muscle for 'spot growth'. Human studies of it: zero; it lasts 20–30 minutes.Animal onlyGray marketChecked Oct 5
- Muscle & strength · Daily shotIGF-1 LR3IGF-1 variantTaken by advanced lifters for muscle growth. Randomized human trials of this version: zero.Animal onlyGray marketChecked Oct 18
- Muscle & strength · Weekly shotMGFIGF-1 variantLifters inject it into a muscle right after training. Human trials: zero; it lasts 5–7 minutes.Animal onlyGray marketChecked Oct 18
- Muscle & strength · Weekly shotPEG-MGFIGF-1 variantLonger-lasting MGF, taken with BPC-157 or TB-500 by strength crowds. Human trials: zero.Animal onlyGray marketChecked Oct 18
- Muscle & strength · Weekly shotFLGR-242Myostatin blockerA codenamed follistatin, sold by the company its promoter co-founded. Published studies of it: zero.No dataGray marketChecked Oct 18
Also here: Macimorelin · Sermorelin · GHRP-2 · MK-677 · Anamorelin · CJC-1295 · Ipamorelin · GHRP-6 · Hexarelin · Follistatin-344 · IGF-1 DES · IGF-1 LR3 · MGF · PEG-MGF · FLGR-242
All 18 in Muscle & strength →Injury & recovery 12
FDA Approved 2
- Injury & recovery · Daily shotAbaloparatideHormoneTymlos, for fragile bones, was tested on broken ones. 48 pelvic-fracture patients: no better than placebo.Controlled trialsFDA approvedfor another useChecked Oct 15
- Injury & recovery · Daily shotTeriparatideHormoneForteo, Lilly's osteoporosis shot, tried on fractures. In 159 hip-fracture patients, healing matched placebo.Controlled trialsFDA approvedfor another useChecked Oct 15
Gray Market 10
- Injury & recovery · IV dripCerebrolysinNeurotrophicAlso for Sleep & focusPig-brain extract given for stroke recovery abroad. 90 trials in PubMed; Cochrane found no effect on deaths.Controlled trialsGray marketChecked Oct 11
- Injury & recovery · Daily shotARA-290Repair peptideChased by people with small-fiber nerve pain. Four placebo-controlled trials, 4 weeks each; no Phase 3.Controlled trialsGray marketChecked Oct 18
- Injury & recovery · Daily shotCortexinBioregulatorAlso for Sleep & focusCattle-brain peptides prescribed in Russia for stroke. Trial deaths: 7 of 208 on it, none of 64 on placebo.Controlled trialsGray marketChecked Oct 5
- Injury & recovery · Daily shotBPC-157Repair peptideAlso for GutEvery stubborn-injury guy keeps one in the fridge. 393 papers so far, almost all of them in rats.Human pilotsGray marketChecked Oct 18
- Injury & recovery · Weekly shotTB-500Repair peptideInjected for tendons alongside BPC-157. What's sold is a 7-amino-acid fragment with zero human studies.Animal onlyGray marketChecked Oct 18
- Injury & recoveryB7-33HormoneA cut-down piece of the human hormone relaxin, built to cut scarring. Human trials: zero; mice and rats.Animal onlyGray marketChecked Oct 5
- Injury & recovery · PillCartalaxBioregulatorTaken in Khavinson cycles for the joints. The evidence: rat cartilage cells in a dish, zero human trials.Animal onlyGray marketChecked Oct 18
- Injury & recoveryThymosin Beta-4Repair peptideTB-500’s parent protein, sold for injury repair. In 700 dry-eye patients its eye drops missed both main goals.Animal onlyGray marketChecked Oct 11
- Injury & recoveryBPC-157 FragmentRepair peptideSold as a cheaper cut of BPC-157. Peer-reviewed studies of the fragment itself: zero.No dataGray marketChecked Oct 18
- Injury & recovery · Daily shotPentadeca ArginateRepair peptideAlso for GutClinics sell it as the new BPC for injuries. Peer-reviewed studies of it: 0.No dataGray marketChecked Oct 4
Also here: Teriparatide · Cortexin · BPC-157 · TB-500 · B7-33 · Cartalax · Thymosin Beta-4 · BPC-157 Fragment · Pentadeca Arginate
All 12 in Injury & recovery →Skin & hair 21
FDA Approved 1
Gray Market 20
- Skin & hair · CreamEGFGrowth factorAlso for Injury & recoveryGrowth factor in face serums and Cuba’s ulcer drug Heberprot-P. Its double-blind acne trial: 20 people.Controlled trialsGray marketChecked Oct 15
- Skin & hair · CreamMatrixylCosmetic peptideA wrinkle peptide in 239 US cosmetics (2023). Its largest trial on its own, run by Procter & Gamble: 93 women.Controlled trialsGray marketChecked Oct 18
- Skin & hair · CreamGHK-CuCosmetic peptideAlso for Injury & recoverySold in serums and injected off-label for hair. Its human trials: 12-week face creams, not injections.Human pilotsGray marketChecked Oct 18
- Skin & hair · Daily shotMelanotan IIMelanocortinAlso for Libido & hormonesInjected for a sunless tan and a libido kick. The tanning trial behind it had 3 people, in 1996.Human pilotsGray marketMole changes in case reportsChecked Oct 18
- Skin & hair · CreamArgirelineCosmetic peptideSold as Botox in a jar. FDA researchers found about 0.22% of it reaches living skin.Human pilotsGray marketChecked Oct 18
- Skin & hair · CreamDecapeptide-12Cosmetic peptideSold in creams for melasma and dark spots. Its best trial: five women, one split-face study.Human pilotsGray marketChecked Oct 18
- Skin & hair · CreamPentapeptide-18Cosmetic peptideSold in wrinkle serums with Argireline. Its maker's 28-day test: 11.64% shallower wrinkles in 14 volunteers.Human pilotsGray marketChecked Oct 18
- Skin & hair · CreamAHK-CuCosmetic peptideSold in hair-growth serums as GHK-Cu's scalp cousin. The whole case rests on one 2007 lab paper.Animal onlyGray marketChecked Oct 18
- Skin & hair · CreamGHK-Cu FragmentCosmetic peptideGHK-Cu without the copper, for creams that also carry vitamin C. Randomized human trials of it: zero.Animal onlyGray marketChecked Oct 18
- Skin & hair · CreamNonapeptide-1Cosmetic peptideSold in brightening creams at 1–2%. Independent human trials: zero; the data are the maker's.Animal onlyGray marketChecked Oct 18
- Skin & hair · CreamPal-GHKCosmetic peptideHalf of the Matrixyl 3000 combo. Its best evidence is a 93-woman trial of a different peptide.Animal onlyGray marketChecked Oct 18
- Skin & hair · CreamRiginCosmetic peptideHalf of Matrixyl 3000, sold as anti-inflammaging. Trials of Rigin alone: zero; the data are the supplier's.Animal onlyGray marketChecked Oct 18
- Skin & hair · CreamSNAP-8Cosmetic peptideA longer Argireline analog, sold in wrinkle creams. Peer-reviewed human trials: zero.Animal onlyGray marketChecked Oct 18
- Skin & hair · CreamSyn-AkeCosmetic peptideA snake-venom mimic in wrinkle creams. Its evidence: the maker's own 28-day panels.Animal onlyGray marketChecked Oct 18
- Skin & hair · CreamSyn-CollCosmetic peptideUsed at 2–4% in serums to push collagen. The claims come from supplier studies; independent trials: zero.Animal onlyGray marketChecked Oct 18
- Skin & hair · CreamTripeptide-29Cosmetic peptideA collagen fragment in creams, at 1–5%. Trials of creams with it as the active: zero.Animal onlyGray marketChecked Oct 13
- Skin & hair · CreamVialoxCosmetic peptideSold as a Botox alternative. Its '49% wrinkle reduction' is a supplier figure; peer-reviewed trials: zero.Animal onlyGray marketChecked Oct 18
- Skin & hairWaglerin-1NeurotoxinA lethal pit-viper neurotoxin, studied in labs. Wrinkle creams use a small mimic; human trials: zero.Animal onlyGray marketLethal snake-venom neurotoxinChecked Oct 18
- Skin & hair · CreamPal-AHKCosmetic peptideUsed in hair serums, copper-free. Peer-reviewed trials of this version: zero.No dataGray marketChecked Oct 18
- Skin & hair · CreamPalmitoyl Dipeptide-6Cosmetic peptideSold in firming serums at 1–4%. Peer-reviewed trials: zero; the claims come from supplier dossiers.No dataGray marketChecked Oct 18
Also here: GHK-Cu · Melanotan II · Argireline · Decapeptide-12 · Pentapeptide-18 · AHK-Cu · GHK-Cu Fragment · Nonapeptide-1 · Pal-GHK · Rigin · SNAP-8 · Syn-Ake · Syn-Coll · Tripeptide-29 · Vialox · Waglerin-1 · Pal-AHK · Palmitoyl Dipeptide-6
All 21 in Skin & hair →Sleep & focus 18
FDA Approved 2
- Sleep & focus · Nasal sprayOxytocinHormoneA nose spray pitched for mood and bonding. Approved in 1962 for labor; the nasal-spray trials are split.Controlled trialsFDA approvedfor another useChecked Oct 13
- Sleep & focus · PillMethylene BlueMitochondrialBiohackers take drops for brain energy. Its one brain study: a single 280 mg dose, 26 people, in 2016.Human pilotsFDA approvedfor another useBoxed warning: serotonin syndromeChecked Oct 18
Gray Market 16
- Sleep & focus · Nasal spraySelankNootropicRussian nasal drops for anxiety, approved there in 2009. Every trial so far is Russian.Controlled trialsGray marketChecked Oct 13
- Sleep & focus · PillBromantaneSmall moleculeRussian doctors prescribe it for burnout and fatigue. Every trial so far is Russian; WADA banned it in 1997.Controlled trialsGray marketChecked Oct 18
- Sleep & focus · Nasal spraySemaxNootropicAlso for Injury & recoveryA Russian stroke drug that biohackers spray for focus. Its key stroke trial had 30 patients, in 1997.Human pilotsGray marketChecked Oct 13
- Sleep & focus · Daily shotDSIPNeuropeptideInjected before bed for deeper sleep. A 1992 double-blind insomnia trial called it 'not likely' to help.Human pilotsGray marketChecked Oct 13
- Sleep & focus · PillNoopeptNootropicSold in US supplements as a memory booster. 20 years on the Russian market; no placebo trial published.Human pilotsGray marketChecked Oct 5
- Sleep & focus · Daily shotPinealonBioregulatorAlso for Injury & recoveryLongevityUsed in Russia after brain injury. Its best study: a 72-patient Russian report in the developers' patent.Human pilotsGray marketChecked Oct 13
- Sleep & focus · PillDihexaNeurotrophicA lab molecule pitched as a memory drug. Human trials: zero.Animal onlyGray marketChecked Oct 11
- Sleep & focusCortagenBioregulatorA synthetic Cortexin, Russia's brain drug. Its best result: rat nerves regrew 27% faster, in one lab.Animal onlyGray marketChecked Oct 18
- Sleep & focus · PillCyclic Glycine-ProlineNootropicA two-amino-acid ring sold in blackcurrant capsules for the brain. Its 126-person trial posted no results.Animal onlyGray marketChecked Oct 5
- Sleep & focusDNSP-11NeurotrophicEleven amino acids copied from a brain growth protein, for Parkinson's. Human trials: zero; monkeys: three.Animal onlyGray marketChecked Oct 5
- Sleep & focus · Daily shotFGLNeurotrophicSold to nootropic buyers as a memory peptide. Its only published human study: a safety test in 24 men.Animal onlyGray marketNeuron loss in healthy young ratsChecked Oct 4
- Sleep & focusP21NeurotrophicNootropic buyers order it for new brain cells. Fifteen papers, one lab, mice only; human trials: zero.Animal onlyGray marketChecked Oct 18
- Sleep & focus · Nasal sprayPE-22-28NootropicPitched as a fast antidepressant, sold as a nasal spray. Human trials: zero; its mood data are one lab’s mice.Animal onlyGray marketChecked Oct 5
- Sleep & focus · Nasal sprayDS5NootropicA vendor-made nasal spray of Dihexa and Semax. Trials of the blend: zero, and the ratios vary by vendor.No dataGray marketChecked Oct 18
- Sleep & focus · Nasal sprayN-Acetyl SelankNootropicA capped Selank, sold for anxiety. Studies of the capped version: zero.No dataGray marketChecked Oct 18
- Sleep & focus · Nasal sprayN-Acetyl SemaxNootropicSold as a longer-lasting Semax. Trials of the capped version: zero; the parent has two Russian stroke trials.No dataGray marketChecked Oct 18
Also here: Methylene Blue · Semax · DSIP · Noopept · Pinealon · Dihexa · Cortagen · Cyclic Glycine-Proline · DNSP-11 · FGL · P21 · PE-22-28 · DS5 · N-Acetyl Selank · N-Acetyl Semax
All 18 in Sleep & focus →Libido & hormones 15
FDA Approved 9
- Libido & hormones · ShotPT-141MelanocortinApproved for women's low desire, used mostly off-label by men. The approval trials: 1,247 women, zero men.Approved drugFDA approvedChecked Oct 18
- Libido & hormones · PillClomipheneSERMMen take a women's fertility pill off-label to raise testosterone. Approved since 1967, for women only.Approved drugFDA approvedVision changes may be irreversibleChecked Oct 15
- Libido & hormones · PillDesmopressinHormoneDDAVP: prescribed for a missing water hormone. Of 215 clinic patients, 30.7% had low sodium over 12 months.Approved drugFDA approvedLow blood sodium can be fatalChecked Oct 14
- Libido & hormones · Weekly shotEPOHormoneSold as Epogen for anemia; athletes dope with EPO. In 48 trained cyclists, EPO didn't beat placebo in a race.Approved drugFDA approvedBoxed warning: death, stroke, clotsChecked Oct 15
- Libido & hormones · Daily shotHCGHormoneMen on testosterone use it to stay fertile. The standard 500 IU every-other-day dose comes from a 2005 study.Approved drugFDA approvedChecked Oct 18
- Libido & hormones · Daily shotHMGHormoneUrine-derived hormones men add to hCG to make sperm. FDA-approved only for women's IVF, 20 days max.Approved drugFDA approvedChecked Oct 13
- Libido & hormones · Daily shotInsulinHormoneAlso for Muscle & strength8 million Americans need it for diabetes; some bodybuilders inject it for size. Misuse can kill.Approved drugFDA approvedHypoglycemia can be fatalChecked Oct 18
- Libido & hormones · Weekly shotTestosteroneHormoneAlso for Muscle & strengthPrescribed for low testosterone; also the original anabolic steroid. Normal is 300–1,000 ng/dL.Approved drugFDA approvedChecked Oct 18
- Libido & hormones · Monthly shotTriptorelinHormoneBodybuilders use one shot to 'restart' testosterone. It's approved to shut testosterone off, within 3–4 weeks.Approved drugFDA approvedChecked Oct 14
Compounded Rx 2
- Libido & hormones · PillEnclomiphene CitrateSERMMen's clinics prescribe it to raise testosterone and keep fertility. The FDA turned it down in 2015.Controlled trialsCompounded RxChecked Oct 18
- Libido & hormones · Daily shotGonadorelinHormoneClinics swap it in for hCG on TRT. It lasts 2–10 minutes in the blood, and studies of that use are thin.Controlled trialsCompounded RxChecked Oct 18
Gray Market 4
- Libido & hormones · Daily shotKisspeptinNeuropeptideClinics sell it as a TRT add-on. Its Phase 2 trials, from two hospital groups, never tested that.Controlled trialsGray marketChecked Oct 14
- Libido & hormones · Daily shotProstamaxBioregulatorSold online for prostate trouble. Peer-reviewed human studies: zero; two patents, rat tissue, cells in a dish.Animal onlyGray marketChecked Oct 5
- Libido & hormones · PillTestagenBioregulatorTaken in Russia for falling testosterone. The evidence: chickens from one lab, plus one 36-man Russian report.Animal onlyGray marketChecked Oct 18
- Libido & hormones · PillZuclomipheneSERMClomiphene's other half, tested for hot flashes. Its only Phase 2 result is an unpublished interim readout.Animal onlyGray marketChecked Oct 18
Also here: PT-141 · HCG · HMG · Insulin · Testosterone · Triptorelin · Enclomiphene Citrate · Gonadorelin · Kisspeptin · Prostamax · Testagen · Zuclomiphene
All 15 in Libido & hormones →Longevity 16
FDA Approved 1
Compounded Rx 2
- Longevity · IV dripNAD+MitochondrialClinics sell it by IV because levels halve between 20 and 60. The trials mostly tested pills, not drips.Human pilotsCompounded RxChecked Oct 18
- Longevity · PillGlutathioneAntioxidantAlso for Skin & hairSold as an IV drip at wellness clinics. Its best trial: 54 adults, oral doses, body stores up over 6 months.Human pilotsCompounded RxChecked Oct 18
Gray Market 13
- Longevity · Daily shotEpithalonBioregulatorRussia's longevity peptide, taken in 10-day courses. Its famous 266-person study tested the pineal extract.Human pilotsGray marketChecked Oct 18
- Longevity · Weekly shotMOTS-cMitochondrialAlso for Weight lossA peptide from mitochondrial DNA, pitched as exercise in a bottle. Human trials of it injected: zero.Animal onlyGray marketChecked Oct 18
- Longevity · Weekly shotKlothoHormoneSold as the protein that made mice live longer. Tested on 18 old monkeys' memory; no published human study.Animal onlyGray marketChecked Oct 18
- LongevityHumaninMitochondrialA mitochondrial peptide sold for longevity. Twenty years of cell and rodent work; human trials: zero.Animal onlyGray marketChecked Oct 18
- Longevity · PillBronchogenBioregulatorLongevity fans take it in capsule cycles for the lungs. Randomized human trials: zero.Animal onlyGray marketChecked Oct 18
- Longevity · PillCardiogenBioregulatorLongevity fans run 10–20 day capsule cycles for the heart. Randomized human trials: zero.Animal onlyGray marketChecked Oct 18
- Longevity · PillChonlutenBioregulatorTaken with Bronchogen in Khavinson cycles for the airways. Randomized human trials: zero.Animal onlyGray marketChecked Oct 18
- LongevityFOXO4-DRICell-killing peptideSold to longevity buyers as a zombie-cell killer. Human data: none; one 2017 mouse paper started it.Animal onlyGray marketChecked Oct 18
- Longevity · PillOvagenBioregulatorAlso for GutTaken for liver and gut support. One lab's research, zero human trials; nothing to do with ovaries.Animal onlyGray marketChecked Oct 18
- Longevity · PillPancragenBioregulatorUsed in Russian clinics alongside diabetes care. The evidence: 20 years of Russian case series.Animal onlyGray marketChecked Oct 18
- Longevity · PillVesugenBioregulatorUsed in Khavinson cycles for blood vessels. The evidence: cell studies and three small Russian reports.Animal onlyGray marketChecked Oct 18
- Longevity · Daily shotN-Acetyl-EpithalonBioregulatorEpithalon with chemical caps, sold as longer-lasting. Human studies of the capped version: zero.No dataGray marketChecked Oct 18
- Longevity · PillVesiluteBioregulatorA two-amino-acid peptide sold in Russia for the bladder. Peer-reviewed studies in animals or people: zero.No dataGray marketChecked Oct 18
Also here: SS-31 · MOTS-c · Klotho · Humanin · Bronchogen · Cardiogen · Chonluten · FOXO4-DRI · Ovagen · Pancragen · Vesugen · N-Acetyl-Epithalon · Vesilute
All 16 in Longevity →Immunity 12
Compounded Rx 1
Gray Market 10
- Immunity · Weekly shotThymosin Alpha-1Thymic peptideApproved abroad for hepatitis B and as an immune enhancer. Its 1,106-patient sepsis trial: no fewer deaths.Controlled trialsGray marketChecked Oct 18
- Immunity · Daily shotThymulinThymic peptideA zinc-charged thymus hormone, often confused with Thymalin. 50 years of research, mostly in rodents.Controlled trialsGray marketChecked Oct 18
- Immunity · Daily shotThymagenBioregulatorTwo amino acids, sold in Moscow pharmacies as Thymogen for immunity. Western randomized trials: zero.Human pilotsGray marketChecked Oct 18
- Immunity · Daily shotThymalinBioregulatorAlso for LongevityA calf-thymus extract used in Russia since 1982. Its famous 266-person aging study came from its developers.Human pilotsGray marketChecked Oct 18
- ImmunityLL-37AntimicrobialInjected for immune support. Its roughly 10 small human trials tested it on leg ulcers, not in shots.Animal onlyGray marketChecked Oct 13
- Immunity · PillCrystagenBioregulatorSold in Russia as an immune-support supplement capsule. Placebo-controlled human trials: zero.Animal onlyGray marketChecked Oct 5
- ImmunityLivagenBioregulatorAlso for LongevityPitched for liver and immune support in Khavinson cycles. Good randomized human trials: zero.Animal onlyGray marketChecked Oct 13
- ImmunityNeurokinin ANeuropeptideInhaled in labs to tighten airways and test asthma drugs. Not a therapy: the 3 drugs in its family block it.Animal onlyGray marketChecked Oct 18
- ImmunityPNC-27Cell-killing peptideSold online as a cancer cure. Human trials: zero; FDA found bacteria in a sample it tested.Animal onlyGray marketFDA warned patients against itChecked Oct 5
- ImmunityVilonBioregulatorAlso for LongevityA Khavinson dipeptide taken in cycles for immunity. Randomized human trials of it alone: zero.Animal onlyGray marketChecked Oct 18
In Trials Only 1
Also here: VIP · Thymagen · Thymalin · LL-37 · Crystagen · Livagen · Neurokinin A · PNC-27 · Vilon
All 12 in Immunity →Gut 3
FDA Approved 1
Gray Market 2
- Gut · PillLarazotideRepair peptidePromoted online for IBD and celiac. In its largest trial 1 of 3 doses beat placebo; Phase 3 stopped in 2022.Controlled trialsGray marketChecked Oct 18
- Gut · PillKPVMelanocortinAlso for Skin & hairTaken for gut and skin flares. Its best evidence: two 2008 mouse-colitis papers; human trials: zero.Animal onlyGray marketChecked Oct 18
No page for that yet
If it’s a real compound, Kalios hasn’t written it up.